Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Homology Medicines Inc (FIXX)

Homology Medicines Inc (FIXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Homology Medicines: Q3 Earnings Snapshot

Homology Medicines: Q3 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q2 Earnings Snapshot

Homology Medicines: Q2 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Homology Medicines: Q1 Earnings Snapshot

Homology Medicines: Q1 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -35.90% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 2.99 (-8.28%)
FIXX : 16.8246 (+0.77%)
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of 37.78% and 7.30%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AMPH : 42.21 (-0.52%)
FIXX : 16.8246 (+0.77%)
BridgeBio Pharma (BBIO) Moves 9.7% Higher: Will This Strength Last?

BridgeBio Pharma (BBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength...

BBIO : 29.10 (+1.29%)
FIXX : 16.8246 (+0.77%)
Homology Medicines (FIXX) Reports Q4 Loss, Misses Revenue Estimates

Homology Medicines (FIXX) delivered earnings and revenue surprises of -17.65% and 23.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FIXX : 16.8246 (+0.77%)
SLGL : 0.6983 (-6.27%)
Homology Medicines: Q4 Earnings Snapshot

Homology Medicines: Q4 Earnings Snapshot

FIXX : 16.8246 (+0.77%)
Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -41.10% and 8.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 28.96 (-3.47%)
FIXX : 16.8246 (+0.77%)
BridgeBio Pharma (BBIO) Reports Q4 Loss, Lags Revenue Estimates

BridgeBio Pharma (BBIO) delivered earnings and revenue surprises of -1.16% and 84.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BBIO : 29.10 (+1.29%)
FIXX : 16.8246 (+0.77%)

Barchart Exclusives

3 Dividend Kings That Cut (Or Will Cut) Their Dividends
Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar